Literature DB >> 25404797

Stress-induced cardiomyopathy following cesarean delivery under general anesthesia.

G Gnanavelu1, D B D Sathiakumar1, M K Narasimhan1, M Sugantha Priya1.   

Abstract

Entities:  

Year:  2013        PMID： 25404797      PMCID： PMC4228031          DOI： 10.1007/s13224-013-0421-3

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN： 0975-6434


× No keyword cloud information.
  6 in total

1.  Takotsubo syndrome during induction of general anaesthesia.

Authors:  M Jabaudon; M Bonnin; F Bolandard; S Chanseaume; C Dauphin; J E Bazin
Journal:  Anaesthesia       Date:  2007-05       Impact factor: 6.955

2.  Guidelines for diagnosis of takotsubo (ampulla) cardiomyopathy.

Authors:  Sachio Kawai; Akira Kitabatake; Hitonobu Tomoike
Journal:  Circ J       Date:  2007-06       Impact factor: 2.993

3.  Images in cardiovascular medicine. Acute reversible stress-induced cardiomyopathy associated with cesarean delivery under spinal anesthesia.

Authors:  Ettore Crimi; Aaron Baggish; Lisa Leffert; May C M Pian-Smith; James L Januzzi; Yandong Jiang
Journal:  Circulation       Date:  2008-06-10       Impact factor: 29.690

Review 4.  Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction.

Authors:  Kevin A Bybee; Tomas Kara; Abhiram Prasad; Amir Lerman; Greg W Barsness; R Scott Wright; Charanjit S Rihal
Journal:  Ann Intern Med       Date:  2004-12-07       Impact factor: 25.391

5.  [Pulmonary edema related to administration of 15-methyl-prostaglandin F2alpha during a cesarean section].

Authors:  M R Rodríguez de la Torre; J I Gallego Alonso; M Gil Fernández
Journal:  Rev Esp Anestesiol Reanim       Date:  2004-02

6.  Transient left ventricular ballooning (tako-tsubo cardiomyopathy) soon after intravenous ergonovine injection following caesarean delivery.

Authors:  Rodolfo Citro; Marco Pascotto; Gennaro Provenza; Giovanni Gregorio; Eduardo Bossone
Journal:  Int J Cardiol       Date:  2008-08-15       Impact factor: 4.164
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.